Palouse Capital Management Inc. reduced its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 11.0% in the 4th quarter, Holdings Channel reports. The firm owned 58,162 shares of the pharmacy operator’s stock after selling 7,207 shares during the quarter. Palouse Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $4,224,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Northpointe Capital LLC raised its position in shares of Walgreens Boots Alliance by 4.6% in the 2nd quarter. Northpointe Capital LLC now owns 20,244 shares of the pharmacy operator’s stock worth $1,585,000 after acquiring an additional 889 shares in the last quarter. Legal & General Group Plc raised its position in shares of Walgreens Boots Alliance by 5.2% in the 2nd quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after acquiring an additional 223,186 shares in the last quarter. Allegis Investment Advisors LLC raised its position in shares of Walgreens Boots Alliance by 18.3% in the 2nd quarter. Allegis Investment Advisors LLC now owns 8,421 shares of the pharmacy operator’s stock worth $659,000 after acquiring an additional 1,300 shares in the last quarter. Gamco Investors INC. ET AL raised its position in shares of Walgreens Boots Alliance by 4.5% in the 2nd quarter. Gamco Investors INC. ET AL now owns 464,409 shares of the pharmacy operator’s stock worth $36,368,000 after acquiring an additional 19,795 shares in the last quarter. Finally, Ballentine Partners LLC raised its position in shares of Walgreens Boots Alliance by 8.7% in the 2nd quarter. Ballentine Partners LLC now owns 3,825 shares of the pharmacy operator’s stock worth $307,000 after acquiring an additional 305 shares in the last quarter. 61.24% of the stock is owned by institutional investors and hedge funds.

Several research analysts have recently weighed in on WBA shares. Pivotal Research lowered their price objective on Walgreens Boots Alliance from $85.00 to $73.00 and set a “hold” rating for the company in a research report on Tuesday, October 24th. Deutsche Bank started coverage on Walgreens Boots Alliance in a research report on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective for the company. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective for the company in a research report on Saturday, January 13th. Finally, Jefferies Group set a $93.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Sunday, October 29th. Eleven investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average price target of $85.53.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $68.46 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The company has a market capitalization of $67,820.00, a PE ratio of 18.91, a PEG ratio of 1.21 and a beta of 1.18. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to the consensus estimate of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. During the same period last year, the business posted $1.10 EPS. analysts anticipate that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.34%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.

Walgreens Boots Alliance declared that its board has initiated a share repurchase plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to buy shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its shares are undervalued.

In other news, insider Stefano Pessina bought 98,858 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 15th. The stock was bought at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 14.80% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Palouse Capital Management Inc. Has $4.22 Million Position in Walgreens Boots Alliance Inc (WBA)” was published by Daily Political and is owned by of Daily Political. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this news story can be accessed at https://www.dailypolitical.com/2018/02/10/palouse-capital-management-inc-has-4-22-million-position-in-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.